Pleiotropic Effects of Sodium-Glucose Cotransporter-2 Inhibitors: Renoprotective Mechanisms beyond Glycemic Control
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Pleiotropic Effects of Sodium-Glucose Cotransporter-2 Inhibitors: Renoprotective Mechanisms beyond Glycemic Control
Authors
Keywords
-
Journal
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Volume 22, Issue 9, Pages 4374
Publisher
MDPI AG
Online
2021-04-23
DOI
10.3390/ijms22094374
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Treatment of Diabetic Kidney Disease: Current and Future
- (2021) Tomotaka Yamazaki et al. Diabetes & Metabolism Journal
- Assessing the Risk for Gout With Sodium–Glucose Cotransporter-2 Inhibitors in Patients With Type 2 Diabetes
- (2020) Michael Fralick et al. ANNALS OF INTERNAL MEDICINE
- Inflammatory Targets in Diabetic Nephropathy
- (2020) Javier Donate-Correa et al. Journal of Clinical Medicine
- Lipotoxicity and Diabetic Nephropathy: Novel Mechanistic Insights and Therapeutic Opportunities
- (2020) Lucas Opazo-Ríos et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Nifedipine Upregulates ATF6-α, Caspases -12, -3, and -7 Implicating Lipotoxicity-Associated Renal ER Stress
- (2020) Chiung-Chi Peng et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Canagliflozin ameliorates obesity by improving mitochondrial function and fatty acid oxidation via PPARα in vivo and in vitro
- (2020) Dan Wei et al. LIFE SCIENCES
- Targeting NF-κB by the Cell-Permeable NEMO-Binding Domain Peptide Improves Albuminuria and Renal Lesions in an Experimental Model of Type 2 Diabetic Nephropathy
- (2020) Lucas Opazo-Ríos et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Uric acid and risk of diabetic kidney disease
- (2020) Michael Mauer et al. JOURNAL OF NEPHROLOGY
- The Vicious Cycle of Renal Lipotoxicity and Mitochondrial Dysfunction
- (2020) Mengyuan Ge et al. Frontiers in Physiology
- Cardiovascular and Renal Outcomes with Empagliflozin in Heart Failure
- (2020) Milton Packer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Dapagliflozin in Patients with Chronic Kidney Disease
- (2020) Hiddo J.L. Heerspink et al. NEW ENGLAND JOURNAL OF MEDICINE
- Dyslipidemia in Kidney Disorders: Perspectives on Mitochondria Homeostasis and Therapeutic Opportunities
- (2020) Pei-Hui Lin et al. Frontiers in Physiology
- Renal haemodynamic and protective effects of renoactive drugs in type 2 diabetes: Interaction with SGLT2 inhibitors
- (2020) Rosalie A. Scholtes et al. NEPHROLOGY
- ATF6α downregulation of PPARα promotes lipotoxicity-induced tubulointerstitial fibrosis
- (2019) Tzu-Ming Jao et al. KIDNEY INTERNATIONAL
- Uric acid and the cardio‐renal effects of SGLT2 inhibitors
- (2019) Clifford J. Bailey DIABETES OBESITY & METABOLISM
- What does sodium‐glucose co‐transporter 1 inhibition add: Prospects for dual inhibition
- (2019) Jessica A. Dominguez Rieg et al. DIABETES OBESITY & METABOLISM
- Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy
- (2019) Vlado Perkovic et al. NEW ENGLAND JOURNAL OF MEDICINE
- Current Progress in Pharmacogenetics of Second-Line Antidiabetic Medications: Towards Precision Medicine for Type 2 Diabetes
- (2019) Chan Heo et al. Journal of Clinical Medicine
- Evaluation of Glomerular Hemodynamic Function by Empagliflozin in Diabetic Mice Using In Vivo Imaging
- (2019) Kengo Kidokoro et al. CIRCULATION
- Dapagliflozin rescues endoplasmic reticulum stress-mediated cell death
- (2019) Ryo Shibusawa et al. Scientific Reports
- Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction
- (2019) John J.V. McMurray et al. NEW ENGLAND JOURNAL OF MEDICINE
- Ipragliflozin Ameliorates Endoplasmic Reticulum Stress and Apoptosis through Preventing Ectopic Lipid Deposition in Renal Tubules
- (2019) Kohshiro Hosokawa et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- The Sodium-Glucose Cotransporter 2 Inhibitor Dapagliflozin Prevents Renal and Liver Disease in Western Diet Induced Obesity Mice
- (2018) Dong Wang et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Renoprotective effects of sodium-glucose cotransporter-2 inhibitors
- (2018) Hiddo J.L. Heerspink et al. KIDNEY INTERNATIONAL
- Ipragliflozin improves mitochondrial abnormalities in renal tubules induced by a high-fat diet
- (2018) Susumu Takagi et al. Journal of Diabetes Investigation
- Analysis of the Global Burden of Disease study highlights the global, regional, and national trends of chronic kidney disease epidemiology from 1990 to 2016
- (2018) Yan Xie et al. KIDNEY INTERNATIONAL
- SLC2A9 (GLUT9) mediates urate reabsorption in the mouse kidney
- (2018) Muriel Auberson et al. PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY
- SGLT2 inhibitors for primary and secondary prevention of cardiovascular and renal outcomes in type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials
- (2018) Thomas A Zelniker et al. LANCET
- Emerging role of Unfolded Protein Response (UPR) mediated proteotoxic apoptosis in diabetes
- (2018) Vivek Kumar Pandey et al. LIFE SCIENCES
- Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes
- (2018) Stephen D. Wiviott et al. NEW ENGLAND JOURNAL OF MEDICINE
- Impacts of Diabetes and an SGLT2 Inhibitor on the Glomerular Number and Volume in db/db Mice, as Estimated by Synchrotron Radiation Micro-CT at SPring-8
- (2018) Yumi Takiyama et al. EBioMedicine
- Predictive Value of Cortical Thickness Measured by Ultrasonography for Renal Impairment: A Longitudinal Study in Chronic Kidney Disease
- (2018) Shotaro Hoi et al. Journal of Clinical Medicine
- Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes
- (2017) Bruce Neal et al. NEW ENGLAND JOURNAL OF MEDICINE
- Uric acid causes kidney injury through inducing fibroblast expansion, Endothelin-1 expression, and inflammation
- (2017) Muhammad Mansyur Romi et al. BMC Nephrology
- Endoplasmic reticulum stress signaling and chemotherapy resistance in solid cancers
- (2017) T Avril et al. Oncogenesis
- Factors Affecting Canagliflozin-Induced Transient Urine Volume Increase in Patients with Type 2 Diabetes Mellitus
- (2016) Hiroyuki Tanaka et al. ADVANCES IN THERAPY
- Lipotoxicity as a trigger factor of renal disease
- (2016) Adriana Izquierdo-Lahuerta et al. JOURNAL OF NEPHROLOGY
- Mitochondrial dysfunction in obesity-related kidney disease: a novel therapeutic target
- (2016) Chengyuan Tang et al. KIDNEY INTERNATIONAL
- Empagliflozin and Progression of Kidney Disease in Type 2 Diabetes
- (2016) Christoph Wanner et al. NEW ENGLAND JOURNAL OF MEDICINE
- Energy Balance After Sodium–Glucose Cotransporter 2 Inhibition
- (2015) Giulia Ferrannini et al. DIABETES CARE
- Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes
- (2015) Bernard Zinman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Urate lowering therapy to improve renal outcomes in patients with chronic kidney disease: systematic review and meta-analysis
- (2015) Tahir Kanji et al. BMC Nephrology
- Nephroprotection by Hypoglycemic Agents: Do We Have Supporting Data?
- (2015) Jose Górriz et al. Journal of Clinical Medicine
- The Concept and the Epidemiology of Diabetic Nephropathy Have Changed in Recent Years
- (2015) Alberto Martínez-Castelao et al. Journal of Clinical Medicine
- SGLT2 inhibitor lowers serum uric acid through alteration of uric acid transport activity in renal tubule by increased glycosuria
- (2014) Yukihiro Chino et al. BIOPHARMACEUTICS & DRUG DISPOSITION
- Functional Role of Glucose Metabolism, Osmotic Stress, and Sodium-Glucose Cotransporter Isoform-Mediated Transport on Na+/H+ Exchanger Isoform 3 Activity in the Renal Proximal Tubule
- (2014) T. D. Pessoa et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Sodium–glucose linked transporter-2 inhibitors: potential for renoprotection beyond blood glucose lowering?
- (2013) Richard E. Gilbert KIDNEY INTERNATIONAL
- Effects of uric acid-lowering therapy on renal outcomes: a systematic review and meta-analysis
- (2013) Bhadran Bose et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Acute and chronic effects of SGLT2 blockade on glomerular and tubular function in the early diabetic rat
- (2011) Scott C. Thomson et al. AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY
- Olmesartan for the Delay or Prevention of Microalbuminuria in Type 2 Diabetes
- (2011) Hermann Haller et al. NEW ENGLAND JOURNAL OF MEDICINE
- Biology of Human Sodium Glucose Transporters
- (2011) Ernest M. Wright et al. PHYSIOLOGICAL REVIEWS
- Dapagliflozin, a Novel, Selective SGLT2 Inhibitor, Improved Glycemic Control Over 2 Weeks in Patients With Type 2 Diabetes Mellitus
- (2009) B Komoroski et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Tubuloglomerular feedback: mechanistic insights from gene-manipulated mice
- (2008) Jurgen Schnermann et al. KIDNEY INTERNATIONAL
- Prevalence of albuminuria and renal insufficiency and associated clinical factors in type 2 diabetes: the Japan Diabetes Clinical Data Management study (JDDM15)
- (2008) H. Yokoyama et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More